Risperidone (Addition) -- Adults
Drug information
Section 24: Medicines for mental and behavioural disorders
Application prepared by:
The Mount Sinai School of Medicine, Program in Global Mental Health, New York, NY, USA
Formulation:
Core List
Tablet: 0.25 mg; 1 mg; 2 mg.
Complementary List
Oral solution: 1 mg/ml in 30-ml bottle.
Risperidone long-acting depot microspheres formulation for deep intramuscular administration 25 mg vial/kit.
-
Application for Inclusion to the 19th Expert Committee on the Selection and Use of Essential Medicines: Risperidone
pdf, 1.68Mb -
Memorandum from Director, Mental Health and Substance Abuse (MSD)
pdf, 152kb -
Comments from Médecins Sans Frontières
pdf, 282kb
Application prepared by:
Massachusetts General Hospital, The Chester M. Pierce MD Division of Global Psychiatry, Boston, MA 02114
Formulation:
Core List
Tablet: 0.25 mg; 0.5 mg; 1 mg; 2 mg; 3 mg; 4 mg; 6 mg.